When was Nervomatrix founded?

Nervomatrix was founded in 2007.

Where is Nervomatrix located?

Nervomatrix is headquartered in Kfar Saba, Israel.

Is Nervomatrix a funded company?

Nervomatrix is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does Nervomatrix rank among its competitors?

Nervomatrix ranks 40th amongst 34 active competitors, of which 4 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Saluda Medical, which secured $30M in Oct, 2025.

Who are the top competitors of Nervomatrix?

Nervomatrix's top competitors include Nalu Medical, Saluda Medical and Nuvectra. Among them, Saluda Medical secured the most recent funding round in October, 2025.

Nervomatrix - 2026 Company Profile & Competitors

Company Details

Nervomatrix has developed, Soleve, a device to relieve back pain. It uses an array of miniature probes coupled into an automated robotic system, a two-dimensional image of skin impedance is generated which helps to analyze data and to look for the lowest points of electrical impedance for targeting active trigger points. It then sends a series of localized, dense electrical pulses to the targeted points, accelerating the release of the body’s natural painkillers and provide pain relief.

Website: nervomatrix.com
Email ID: *****@nervomatrix.com

Key Metrics

Founded Year

2007

Location

Kfar Saba, Israel

Stage

Unfunded

Ranked

40^th among 54 competitors

Similar Companies

Nalu Medical & 52 more

View Nervomatrix's full profile

Nervomatrix has not raised any funding rounds yet.

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Nervomatrix include Nalu Medical, Saluda Medical and Nuvectra. Here is the list of Top 10 competitors of Nervomatrix, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Nalu Medical 2014, Carlsbad (United States), Acquired	Developer of a neurostimulation system for managing intractable chronic pain	$231M	MVM, Gilde Healthcare & 9 others	67/100
2nd	Saluda Medical 2010, Bloomington (United States), Public	Developer of neuromodulation platform measuring biomarkers for chronic neurological condition treatment	$530M	Redmile Group, Wellington & 9 others	66/100
3rd	Nuvectra 2016, Plano (United States), Public	Spinal cord stimulation system for treating of chronic pain of the trunk and/or limbs	-	-	43/100
4th	Biowave 2000, Norwalk (United States), Seed	Innovative pain relief solutions using neurostimulation technology for athletes and chronic pain sufferers	$2.08M	Connecticut Innovations	40/100
5th	Calmare Therapeutics 1968, Fairfield (United States), Funding Raised	Develops devices for the treatment of chronic and neuropathic pain	-	-	34/100
6th	SzeleSTIM 2015, Vienna (Austria), Funding Raised	Developer of smart products for pain treatment	-	EIC Fund, Europa & 1 others	34/100
7th	Stimwave 2010, Pompano Beach (United States), Deadpooled	Developer of smart devices for neuropathic pain monitoring	$9.78M	Prettybrook Partners, Foothill Ventures	34/100
8th	Alpha-Stim 1996, Texas City (United States), Acquired	Develops a non-drug treatment for pain	-	-	32/100
9th	SOLO-DEX 2016, Bozeman (United States), Funding Raised	Developer of a device for peripheral nerve block procedure	-	-	32/100
10th	StimAire 2018, Tucson (United States), Seed	Developer of neural stimulation treatment therapy	$1.56M	UAVenture Capital Fund	30/100
40th	Nervomatrix 2007, Kfar Saba (Israel), Unfunded	A device to relieve back pain	-	-	16/100